# Efficacy and Safety of Lemborexant for Patients With Cirrhosis and Sleep Problems

> **NCT07480096** · PHASE2 · COMPLETED · sponsor: **Indonesia University** · enrollment: 82 (actual)

## Conditions studied

- Cirrhosis
- Liver Cirrhosis
- Sleep Quality
- Insomnia
- Hepatic Encephalopathy

## Interventions

- **DRUG:** Lemborexant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07480096
- **Lead sponsor:** Indonesia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-01
- **Primary completion:** 2025-10-30
- **Final completion:** 2025-10-30
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07480096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07480096, "Efficacy and Safety of Lemborexant for Patients With Cirrhosis and Sleep Problems". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07480096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*